Skip to main content

CITIGROUP INC

Position in ABCL — AbCellera Biologics Inc.

CIK 831001 NEW YORK, NY

Position in ABCL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$56,378
+$26,811 QoQ
Shares Held
7,182
-15.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 150 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABCL Over Time

Shares Held

Position Value (USD)

Derivatives in ABCL

reported options exposure · as of Dec 31, 2021
CallValue
$5,291,000
CallShares
370,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ABCL ranks #297 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABCL

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,378 7,182
2026-03-31 $29,567 8,472
2025-12-31 $28,553 8,349
2025-09-30 $28,902 5,746
2025-06-30 $49,584 14,456
2025-03-31 $9,671 4,337
2024-12-31 $36,964 12,616
2024-09-30 $13,608 5,234
2024-06-30 $234,694 79,289
2024-03-31 $18,300 4,040
2023-12-31 $46,273 8,104
2023-09-30 $19,604 4,262
2023-06-30 $51,814 8,021
2023-03-31 $38,732 5,137
2022-12-31 $77,686 7,669
2022-09-30 $99,670 10,078
2022-06-30 $348,510 32,724
2022-03-31 $107,464 11,022
2021-12-31 $5,291,000 370,000
2021-12-31 $189,489 13,251
2021-09-30 $10,294,548 513,700
2021-09-30 $1,056,108 52,700
2021-09-30 $115,831 5,780
2021-06-30 $6,987,200 317,600
2021-06-30 $2,259,400 102,700
2021-06-30 $168,234 7,647
2021-03-31 $6,792 200